Yutaka Yonemura
Kanazawa University
383 Papers
2.7K Citations
Yutaka Yonemura is an academic researcher from Kanazawa University. The author has contributed to research in topics: Cancer & Metastasis. The author has an hindex of 55, co-authored 370 publications.
Chat about Author
Papers
Neoadjuvant chemotherapy in advanced gastric and esophago-gastric cancer. Meta-analysis of randomized trials.
Federico Coccolini,Matteo Nardi,Giulia Montori,Marco Ceresoli,Andrea Celotti,Stefano Cascinu,Paola Fugazzola,Matteo Tomasoni,Olivier Glehen,Fausto Catena,Yutaka Yonemura,Luca Ansaloni +11 more
TL;DR: NACT reduces the mortality in gastric and esophago-gastric cancer and the overall recurrence rate is reduced by NACT in esophageal cancer.
144
Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination
Yutaka Yonemura,Takashi Fujimura,Sachio Fushida,Shigeru Takegawa,Toru Kamata,Kanji Katayama,Takeo Kosaka,Akio Yamaguchi,Kouichi Miwa,I Miyazaki +9 more
TL;DR: Results suggest the effectiveness of CHPP in the treatment of gastric cancer with peritoneal dissemination with anticancer agents is suggested, and suggest that the PPCH est efficace dans le traitement du cancer gastrique avec dissémination péritonéale.
141
Neoadjuvant treatment of gastric cancer with peritoneal dissemination.
Yutaka Yonemura,Etsurou Bandou,T. Sawa,Y. Yoshimitsu,Yoshio Endou,Takuma Sasaki,Paul H. Sugarbaker +6 more
TL;DR: NIPS can downstage large volume peritoneal dissemination of gastric cancer and is worthy of consideration for phase III clinical investigations.
136
Continuous hyperthermic peritoneal perfusion for the treatment of peritoneal dissemination in gastric cancers and subsequent second-look operation.
Takashi Fujimura,Yutaka Yonemura,Sachio Fushida,Masaaki Urade,Shigeru Takegawa,Toru Kamata,Sugiyama K,Hajime Hasegawa,Kanji Katayama,Koichi Miwa,Itso Miyazaki +10 more
TL;DR: The results supported that CHPP was well tolerated and effective for the treatment of patients with peritoneal dissemination in gastric cancer when combined with anti‐cancer drugs having synergism with hyperthermia.
135
Prophylaxis with intraoperative chemohyperthermia against peritoneal recurrence of serosal invasion-positive gastric cancer
Yutaka Yonemura,Itasu Ninomiya,Masahide Kaji,Kazuhisa Sugiyama,K. Fujimura,Sawa T,Kanji Katayama,Tanaka S,Yasuo Hirono,Kouichi Miwa,I Miyazaki +10 more
TL;DR: In patients with pathologically confirmed serosal invasion-positive tumors, the survival rate of the CHPP group was significantly higher than that of the control group and a survival advantage for stage IV patients was also obtained by CHPP.
134